RESUMEN
Background: Aortic valve fenestration (AVF) is a relatively common anatomical variation, while its rupture is a rare cause of aortic regurgitation (AR), especially following coronary angiography. This case report highlights the importance of echocardiographic evaluation and multidisciplinary discussion for the differential diagnosis of fibroelastoma or endocarditis. Case summary: A 66-year-old man presented with acute shortness of breath following coronary angiography for an inferior ST-elevation myocardial infarction. Echocardiography revealed severe aortic regurgitation associated with a filamentous mobile structure on the non-coronary cusp. A multidisciplinary discussion was conducted to determine the cause of the AR, leading to the patient undergoing aortic valve replacement. A gross inspection of the valve confirmed AVF rupture. Conclusion: Iatrogenic AVF rupture following coronary angiography is an exceptionally rare complication. Thorough echocardiographic evaluation plays a significant role in differentiating AVF rupture from other valve pathologies, such as fibroelastoma, Lambl's excrescence, or endocarditis. Echocardiographic features, including a very thin, linear, and flail-like mobile lesion, the paracommissural location, frequent involvement of the non-coronary cusp, and an eccentric jet of the AR, are suggestive of AVF rupture. While medical history and clinical examination contribute to the diagnostic process, definitive diagnosis relies on surgery and anatomopathology.
RESUMEN
OBJECTIVE: To report the authors' initial experience of transcarotid transcatheter aortic valve replacement (TAVR) managed with ultrasound-guided intermediate cervical plexus block. DESIGN: A single-center prospective study. SETTING: A teaching hospital in Paris, France. PARTICIPANTS: All consecutive patients undergoing a transcarotid TAVR were included. INTERVENTIONS: The ultrasound-guided intermediate cervical plexus block was performed in 28 of 31 patients. In 3 patients, the procedure was scheduled under general anesthesia: 2 because of failure of previous transfemoral procedures under local anesthesia, and 1 for an emergency procedure in a pulmonary edema context. MEASUREMENTS AND MAIN RESULTS: Anesthesia and all perioperative parameters were recorded, as well as any complications after the procedure. Twenty-eight patients were managed with intermediate cervical plexus block and light sedation without any anesthesia-related complication. No conversion to general anesthesia was required. The use of vasopressor was only required in 11% of the patients. In 2 patients, a loss of consciousness after the common carotid artery cross-clamping test occurred, leading to the use of a temporary femoral-carotid shunt; no other change in consciousness was recorded during the procedure. CONCLUSIONS: Ultrasound-guided intermediate cervical plexus block appeared to be an alternative anesthetic technique for carotid TAVR, providing adequate surgical conditions, continuous neurologic monitoring, and arterial pressure stability.
Asunto(s)
Estenosis de la Válvula Aórtica , Bloqueo del Plexo Cervical , Reemplazo de la Válvula Aórtica Transcatéter , Válvula Aórtica/cirugía , Estenosis de la Válvula Aórtica/diagnóstico por imagen , Estenosis de la Válvula Aórtica/cirugía , Bloqueo del Plexo Cervical/efectos adversos , Francia , Humanos , Estudios Prospectivos , Reemplazo de la Válvula Aórtica Transcatéter/efectos adversos , Resultado del Tratamiento , Ultrasonografía IntervencionalRESUMEN
The coronavirus disease 2019 (COVID-19) may lead to an acute respiratory distress syndrome by an inappropriate cytokine response and may predispose to a prothrombotic state through multiple pathways. Both can complicate the management of cardiac surgery with cardiopulmonary bypass, which is known to activate the hemostatic system and to exacerbate systemic inflammatory response. Little is known about the impact of cardiac surgery with cardiopulmonary bypass on viral pneumonia, particularly with the new coronavirus. In this article, we describe the case of a diabetic patient with COVID-19 and a concomitant 3-vessel disease with a formal indication for surgical revascularization, who unexpectedly presented with a high heparin resistance during cardiopulmonary bypass. Emphasis is placed on the importance of multidisciplinary team discussions before surgery, on the thorough preoperative assessment, and on the perioperative management, particularly regarding mechanical ventilation and anticoagulation.
Asunto(s)
COVID-19/complicaciones , Puente Cardiopulmonar/métodos , Intervención Coronaria Percutánea/métodos , SARS-CoV-2 , Humanos , Masculino , Persona de Mediana EdadRESUMEN
We report the perioperative management of a patient with pulmonary hypertension under new-generation treatments who underwent laparoscopic surgery. Preoperatively, arterial catheter, central venous line, and transesophageal echocardiography probe were inserted in addition to standard monitoring. Intraoperatively, inhaled nitric oxide was used because of increasing pressure in the right heart chambers related to the Trendelenburg position and the pneumoperitoneum. The operation finally lasted <2 hours without complication. The prognosis of patients with pulmonary hypertension has evolved since the advent of new management strategies. Thorough preoperative assessment and multidisciplinary discussion in a referral center are essential for medical optimization.
Asunto(s)
Hipertensión Pulmonar/tratamiento farmacológico , Prolapso Rectal/cirugía , Anciano , Antihipertensivos , Bosentán/uso terapéutico , Femenino , Inclinación de Cabeza , Humanos , Hipertensión Pulmonar/complicaciones , Laparoscopía , Cuidados Preoperatorios , Tadalafilo/uso terapéutico , Resultado del TratamientoRESUMEN
BACKGROUND: Guidelines recommend performing atrial fibrillation (AF) catheter ablation without interruption of a direct oral anticoagulants (DOACs) and to administer unfractionated heparin (UFH) for an activated clotting time (ACT) ≥300 seconds, by analogy with vitamin K antagonist (VKA). Nevertheless, pharmacological differences between DOACs and VKA, especially regarding ACT sensitivity and UFH response, prevent extrapolation from VKA to DOACs. HYPOTHESIS: The level of anticoagulation at the time of the procedure in uninterrupted DOAC-treated patients is unpredictable and would complicate intraprocedural UFH administration and monitoring. METHODS: This prospective study included interrupted DOAC-treated patients requiring AF ablation. Preprocedural DOAC concentration ([DOAC]), intraprocedural UFH administration, and ACT values were recorded. A cohort of DOAC-treated patients requiring flutter catheter ablation was considered to illustrate [DOAC] without DOAC interruption. RESULTS: Forty-eight patients underwent AF and 14 patients underwent flutter ablation, respectively. In uninterrupted DOAC-treated patients, [DOAC] ranged from ≤30 to 466 ng/mL. When DOAC were interrupted, from 54 to 218 hours, [DOAC] were minimal (maximum: 36 ng/mL), preventing DOAC-ACT interference. Anyway, ACT values were poorly correlated with UFH doses (R 2 = 0.2256). CONCLUSIONS: Our data showed that uninterrupted DOAC therapy resulted in an unpredictable and highly variable initial level of anticoagulation before catheter ablation. Moreover, even with DOAC interruption preventing interference between DOAC, UFH, and ACT, intraprocedural UFH monitoring was complex. Altogether, our exploratory results call into question the appropriateness of transposing UFH dose protocols, as well as the relevance of ACT monitoring in uninterrupted DOAC-treated patients.
Asunto(s)
Anticoagulantes/administración & dosificación , Fibrilación Atrial/terapia , Aleteo Atrial/terapia , Coagulación Sanguínea/efectos de los fármacos , Ablación por Catéter , Heparina/administración & dosificación , Administración Oral , Adulto , Anciano , Anciano de 80 o más Años , Anticoagulantes/efectos adversos , Fibrilación Atrial/sangre , Fibrilación Atrial/diagnóstico , Fibrilación Atrial/fisiopatología , Aleteo Atrial/sangre , Aleteo Atrial/diagnóstico , Aleteo Atrial/fisiopatología , Ablación por Catéter/efectos adversos , Esquema de Medicación , Monitoreo de Drogas/métodos , Femenino , Francia , Heparina/efectos adversos , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Factores de Tiempo , Resultado del Tratamiento , Tiempo de Coagulación de la Sangre TotalAsunto(s)
Válvula Aórtica/anomalías , Ecocardiografía Transesofágica/métodos , Enfermedades de las Válvulas Cardíacas/diagnóstico por imagen , Enfermedades de las Válvulas Cardíacas/cirugía , Cuidados Preoperatorios/métodos , Válvula Aórtica/diagnóstico por imagen , Válvula Aórtica/cirugía , Enfermedad de la Válvula Aórtica Bicúspide , Femenino , Humanos , Persona de Mediana EdadRESUMEN
BACKGROUND: The benefits of cardiac surgery are sometimes difficult to predict and the decision to operate on a given individual is complex. Machine Learning and Decision Curve Analysis (DCA) are recent methods developed to create and evaluate prediction models. METHODS AND FINDING: We conducted a retrospective cohort study using a prospective collected database from December 2005 to December 2012, from a cardiac surgical center at University Hospital. The different models of prediction of mortality in-hospital after elective cardiac surgery, including EuroSCORE II, a logistic regression model and a machine learning model, were compared by ROC and DCA. Of the 6,520 patients having elective cardiac surgery with cardiopulmonary bypass, 6.3% died. Mean age was 63.4 years old (standard deviation 14.4), and mean EuroSCORE II was 3.7 (4.8) %. The area under ROC curve (IC95%) for the machine learning model (0.795 (0.755-0.834)) was significantly higher than EuroSCORE II or the logistic regression model (respectively, 0.737 (0.691-0.783) and 0.742 (0.698-0.785), p < 0.0001). Decision Curve Analysis showed that the machine learning model, in this monocentric study, has a greater benefit whatever the probability threshold. CONCLUSIONS: According to ROC and DCA, machine learning model is more accurate in predicting mortality after elective cardiac surgery than EuroSCORE II. These results confirm the use of machine learning methods in the field of medical prediction.
Asunto(s)
Técnicas de Apoyo para la Decisión , Mortalidad Hospitalaria , Modelos Logísticos , Aprendizaje Automático , Anciano , Procedimientos Quirúrgicos Cardíacos , Puente Cardiopulmonar/efectos adversos , Puente Cardiopulmonar/métodos , Comorbilidad , Femenino , Humanos , Masculino , Persona de Mediana Edad , Modelos Estadísticos , Curva ROC , Reproducibilidad de los ResultadosRESUMEN
OBJECTIVES: Octogenarians considered for cardiac surgery encounter more complications than other patients. Postoperative complications raise the question of continuation of high-cost care for patients with limited life expectancy. Duration of hospitalization in intensive care after cardiac surgery may differ between octogenarians and other patients. The objectives were evaluating the mortality rate of octogenarians experiencing prolonged hospitalization in intensive care and defining the best cut-off for prolonged intensive care unit length of stay. DESIGN: A single-center observational study. SETTING: A postoperative surgical intensive care unit in a tertiary teaching hospital in Paris, France. PARTICIPANTS: All consecutive patients older than 80 years considered for aortic valve replacement for aortic stenosis were included. MEASUREMENTS AND MAIN RESULTS: Mortality rate was determined among patients experiencing prolonged stay in intensive care with organ failure and without organ failure. An ROC curve determined the optimal cut-off defining prolonged hospitalization in intensive care according to the occurrence of postoperative complications. Multivariate analysis determined risk factors for early death or prolonged intensive care stay. The optimal cut-off defining prolonged intensive care unit length of stay was 4 days. Low ventricular ejection fraction (odds ratio [OR] = 0.95; 95% confidence interval [CI] 0.96-0.83; p = 0.0016), coronary disease (OR = 2.34; 95% CI 1.19-4.85; p = 0.014), and need for catecholamine (OR = 2.79; 95% CI 1.33-5.88; p = 0.0068) were associated with eventful postoperative course. There was not a hospitalization duration beyond which the prognosis significantly worsened. CONCLUSIONS: Prolonged length of stay in ICU without organ failure is not associated with increased mortality. No specific duration of hospitalization in intensive care was associated with increased mortality. Continuation of care should be discussed on an individual basis.
Asunto(s)
Estenosis de la Válvula Aórtica/cirugía , Cuidados Críticos/estadística & datos numéricos , Evaluación Geriátrica/estadística & datos numéricos , Implantación de Prótesis de Válvulas Cardíacas , Tiempo de Internación/estadística & datos numéricos , Complicaciones Posoperatorias/epidemiología , Anciano de 80 o más Años , Válvula Aórtica/cirugía , Femenino , Francia/epidemiología , Prótesis Valvulares Cardíacas , Humanos , Unidades de Cuidados Intensivos , Masculino , Pronóstico , Estudios Prospectivos , Factores de Riesgo , Índice de Severidad de la EnfermedadRESUMEN
BACKGROUND: Management of ticagrelor-induced bleeding is challenging, as no antidote is currently available. Platelet transfusion, usually proposed to reverse antiplatelet drugs, has been suggested to be ineffective but few data are available. OBJECTIVE: To assess the efficacy of platelet supplementation to restore platelet aggregation inhibited by ticagrelor. DESIGN: In vitro study. SETTING: Blood samples were obtained from the French Blood Bank Institute. PARTICIPANTS: Healthy blood donors. INTERVENTIONS: Whole blood from healthy donors was spiked with ticagrelor or aspirin (used as a positive control). MAIN OUTCOME MEASURES: Platelet aggregation was investigated with impedance aggregometry on whole blood [expressed in ohms (V)] and light transmission aggregometry (expressed in %) on platelet-rich plasma using ADP or arachidonic acid as agonists for ticagrelor or aspirin, respectively. Platelet supplementation was defined as the addition of washed platelet suspension increasing at least 60% of whole blood platelet count. RESULTS: Ticagrelor (3.25âmM) inhibited ADP-induced platelet aggregation compared with control either in whole blood (2 vs. 13âV, Pâ<â0.05) or in platelet-rich plasma (15 vs. 75% Pâ<â0.05). Aspirin (25âmM) inhibited arachidonic acid-induced aggregation (1 vs. 7.5âV, Pâ<â0.05 in whole blood and 5 vs. 77.5%, Pâ=â0.01 in platelet-rich plasma). Platelet supplementation completely restored arachidonic acid-induced platelet aggregation in whole blood (10 vs. 1âV, Pâ=â0.008) and platelet-rich plasma (73 vs. 5%, Pâ<â0.01) in aspirin-treated samples, whereas it failed to correct ADP-induced aggregation (2 vs. 2âV in whole blood and 13.5 vs. 15% in platelet-rich plasma, Pâ>â0.05) in ticagrelor-treated samples. We also report a case of a ticagrelor-treated patient in whom platelet transfusion failed to restore ADP-induced platelet aggregation. CONCLUSION: Platelet supplementation restored platelet aggregation in aspirin-spiked but not in ticagrelor-spiked samples. These results do not support the use of platelet transfusion to reverse the effects of ticagrelor.
Asunto(s)
Adenosina/análogos & derivados , Inhibidores de Agregación Plaquetaria/toxicidad , Agregación Plaquetaria/efectos de los fármacos , Transfusión de Plaquetas , Adenosina/toxicidad , Adenosina Difosfato/farmacología , Ácido Araquidónico/farmacología , Aspirina/farmacología , Humanos , Masculino , Persona de Mediana Edad , Pruebas de Función Plaquetaria , TicagrelorRESUMEN
OBJECTIVE: Since stroke and myocardial ischaemia are major causes of perioperative morbidity and mortality associated with carotid endarterectomy, monitoring the brain and ensuring the best haemodynamic stability are important goals of the management. As regional anaesthesia was reported to improve haemodynamic stability during carotid endarterectomy (CEA), we conducted a prospective observational study on the efficacy and safety of ultrasound-guided intermediate cervical plexus blocks (CPB), with early (immediate postoperative) and mid-term (day 30) outcomes in awake patients undergoing CEA. METHODS: After the ethics committee approval, 50 patients undergoing a carotid endarterectomy with CPB from April 2011 to May 2013 were included. Anaesthesia and surgical dissection parameters, early complications and haemodynamic stability were recorded, as well as neurologic and cardiac outcomes initially and one month later. RESULTS: Cervical space was easy to locate by ultrasound in 90% of the patients. The quality of anaesthesia and surgical dissection was good in 86 and 88% of patients, respectively. No conversion to GA was required, secondary to a lack of analgesia. Two patients (4%) had severe hypotension (<100mmHg). Three patients required a shunt after carotid clamping for loss of consciousness with a favourable neurological outcome. We observed one elevation of cTnI (0.95ng·ml(-1)) without ECG change and 1 death occurred after a postoperative haemorrhagic stroke. CONCLUSIONS: The present work reports our first 50 cases of intermediate CPB using ultrasound guidance. The results underline that this technique is easy to perform, safe and reliable, provided good surgical conditions with continuous intraoperative neurologic monitoring and stable haemodynamics are respected.
Asunto(s)
Plexo Cervical/diagnóstico por imagen , Endarterectomía Carotidea/métodos , Bloqueo Nervioso/efectos adversos , Bloqueo Nervioso/métodos , Anciano , Anciano de 80 o más Años , Electrocardiografía , Endarterectomía Carotidea/efectos adversos , Femenino , Hemodinámica , Humanos , Complicaciones Intraoperatorias/fisiopatología , Masculino , Persona de Mediana Edad , Monitoreo Intraoperatorio , Estudios Prospectivos , Resultado del Tratamiento , Ultrasonografía Intervencional , Inconsciencia/etiologíaRESUMEN
We prospectively evaluated the diagnostic accuracy of a new rapid assay (STic Expert HIT) alone or in combination with a clinical score in 90 HIT-suspected patients. The 4Ts score was calculated, and ELISA and serotonin-release assay (SRA) were performed; the average time taken for test results were 2 and 5 days for ELISA and SRA, respectively. The STic test was performed in our laboratory as an evaluation exercise and the result was available in 1 hour, but results were not communicated to the clinicians so as to not influence management. Diagnostic performance of STic test was assessed, alone and in combination with 4Ts score. HIT was diagnosed in 19 patients. The sensitivity, specificity, and positive and negative predictive values for the STic test alone were 95%, 92%, 75%, and 98%, respectively, with an accuracy of 92%. The likelihood ratio for positive and negative results with the STic test was 11.2 and 0.06. The combination of the 4Ts score and the STic test results had a negative predictive value of 100% and a negative likelihood ratio of 0. The favorable performance of the STic test may allow for the rapid exclusion of HIT in combination with a low to intermediate pretest clinical probability. During the subsequent year, using the STic test in real time to rapidly exclude the diagnosis, we observed a 50% reduction in danaparoid administration in HIT-suspected patients.
Asunto(s)
Heparina/efectos adversos , Púrpura Trombocitopénica Idiopática/sangre , Púrpura Trombocitopénica Idiopática/inducido químicamente , Púrpura Trombocitopénica Idiopática/diagnóstico , Serotonina/sangre , Anciano , Anciano de 80 o más Años , Ensayo de Inmunoadsorción Enzimática/métodos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Estudios ProspectivosAsunto(s)
Anticoagulantes/uso terapéutico , Administración del Tratamiento Farmacológico , Atención Perioperativa/métodos , Administración Oral , Anticoagulantes/efectos adversos , Anticoagulantes/farmacocinética , Pruebas de Coagulación Sanguínea , Pérdida de Sangre Quirúrgica , Humanos , Vitamina K/antagonistas & inhibidoresRESUMEN
PURPOSE OF REVIEW: The management of atrial fibrillation has seen marked changes in recent years. This is the result of better knowledge of the pathophysiology and risks factors for atrial fibrillation, better stratification for thromboembolic and bleeding risks, changing practices in anticoagulation management, and the development of new antiarrhythmic drugs. This article focuses on these new issues, with particular attention to their relevance in the perioperative period. RECENT FINDINGS: Improved understanding of the interaction between predisposing factors and the pathophysiological mechanisms of atrial fibrillation is changing management strategies. Preoperative identification of patients at risk for postoperative atrial fibrillation (POAF) is important so that measures such as ß-blockade may be introduced to prevent its occurrence. When POAF does occur, cardioversion is preferred in unstable patients and amiodarone is the most commonly used drug. Owing to the transient nature of POAF and excessive bleeding risk immediately postsurgery, anticoagulation should be used with caution in these patients. The perioperative management of patients on chronic oral anticoagulants is guided by weighing the risk of thromboembolic complications against the risk surgical bleeding. Risk stratification scoring systems and published guidelines facilitate decision-making. New oral anticoagulants offer potentially improved safety profiles over traditional agents; however, their optimal management in the perioperative period remains unknown. SUMMARY: Better knowledge of the pathophysiology of atrial fibrillation and improved awareness of the risks associated with this frequent arrhythmia are continuing to improve the management of patients with chronic atrial fibrillation and new-onset atrial fibrillation in the perioperative period. As with most complex disease processes, treatment decisions must be individualized for each patient and clinical context.
Asunto(s)
Fibrilación Atrial/terapia , Atención Perioperativa/métodos , Anticoagulantes/uso terapéutico , Fibrilación Atrial/epidemiología , Humanos , Incidencia , Factores de RiesgoRESUMEN
OBJECTIVES: Fibroblast migration is an initiating step in fibroproliferation; its involvement during acute lung injury and acute respiratory distress syndrome remains poorly understood. The aims of this study were: 1) to determine whether bronchoalveolar lavage fluids from patients with acute lung injury/acute respiratory distress syndrome modulate lung fibroblast migration; 2) to assess lung fibroblast migration's clinical relevance; and 3) to evaluate the role of the platelet-derived growth factor pathway in this effect. DESIGN: Prospective cohort study. SETTING: Three intensive care units of a large tertiary referral center. PATIENTS: Ninety-three ventilated patients requiring bronchoalveolar lavage fluids were enrolled (48 with acute respiratory distress syndrome, 33 with acute lung injury, and 12 ventilated patients without acute lung injury/acute respiratory distress syndrome). INTERVENTIONS: After bronchoalveolar lavage fluids collection during standard care, the patients were followed up for 28 days and clinical outcomes were recorded. Migration assays were performed by using a Transwell model; bronchoalveolar lavage fluids platelet-derived growth factor and soluble platelet-derived growth factor receptor-α were characterized by Western blot and measured by ELISA. MEASUREMENTS AND MAIN RESULTS: Most of the bronchoalveolar lavage fluids inhibited basal fibroblast migration. Bronchoalveolar lavage fluids chemotactic index increased with severity of lung injury (28% in patients without acute lung injury/acute respiratory distress syndrome and with acute lung injury vs. 91% in acute respiratory distress syndrome patients; p = .016). In acute lung injury/acute respiratory distress syndrome patients, inhibition of basal fibroblast migration by bronchoalveolar lavage fluids below 52% was independently associated with a lower 28-day mortality (odds ratio [95% confidence interval] 0.313 [0.10-0.98], p = .046). Platelet-derived growth factor-related peptides and soluble platelet-derived growth factor-Rα were detected in all bronchoalveolar lavage fluids from acute lung injury/acute respiratory distress syndrome patients. The effect of bronchoalveolar lavage fluids stimulating migration was inhibited by a specific platelet-derived growth factor receptor inhibitor (AG1296). Bronchoalveolar lavage fluids inhibiting migration reversed the effect of rh-platelet-derived growth factor-BB and reduced by 40% the binding of 125I-platelet-derived growth factor-BB to fibroblast cell surface in favor of a role for platelet-derived growth factor-sRα. CONCLUSIONS: : Together, our results suggest that during acute lung injury, fibroblast migration is modulated by bronchoalveolar lavage fluids through a platelet-derived growth factor/platelet-derived growth factor-sRα balance. Migration is associated with clinical severity and patient 28-day mortality.
Asunto(s)
Lesión Pulmonar Aguda/metabolismo , Líquido del Lavado Bronquioalveolar/citología , Movimiento Celular/fisiología , Fibroblastos/fisiología , Factor de Crecimiento Derivado de Plaquetas/metabolismo , Síndrome de Dificultad Respiratoria/metabolismo , Lesión Pulmonar Aguda/epidemiología , Anciano , Western Blotting , Lavado Broncoalveolar , Línea Celular , Inhibidores Enzimáticos/farmacología , Femenino , Humanos , Unidades de Cuidados Intensivos , Interleucina-8/metabolismo , Masculino , Persona de Mediana Edad , Insuficiencia Multiorgánica/mortalidad , Análisis Multivariante , Neutrófilos/metabolismo , Estudios Prospectivos , Receptores del Factor de Crecimiento Derivado de Plaquetas/antagonistas & inhibidores , Respiración Artificial , Síndrome de Dificultad Respiratoria/epidemiología , Índice de Severidad de la Enfermedad , Tirfostinos/farmacologíaRESUMEN
OBJECTIVES: To assess the characteristics and prognosis of patients in whom heparin-induced thrombocytopenia (HIT) was confirmed (HIT+) among suspected HIT patients after having cardiac surgery and to assess the accuracy of two HIT scoring systems. DESIGN: An observational prospective study. SETTING: A cardiac surgery unit of a tertiary center from November 2005 to September 2007. PARTICIPANTS: Of the 1,722 patients who underwent cardiac surgery, 63 were suspected of HIT based on a platelet count <100 × 10(9)/L, a decrease in platelet count of >30%, or the occurrence of a thrombotic event. INTERVENTION: The HIT criteria were as follows: (1) the absence of another cause of thrombocytopenia, (2) positive antiplatelet factor 4 (PF4) antibodies (>0.5 optical density [OD]/mn) on enzyme-linked immunoabsorbent assay, and (3) recovery in platelet count after the discontinuation of heparin and substitution by danaparoid sodium. MEASUREMENTS AND MAIN RESULTS: HIT was confirmed in 24 patients (1.4% [0.8%-1.9%]); 23 belonged to the 984 treated by intravenous unfractionated heparin (IVUH) (2.3% IQ [1.4%-3.3%]) and 1 to the 738 treated by low-molecularweight heparin (0.14% [0.13%-0.4%]) (OD = 17.6; 95% confidence interval, 2.4-131; p < 0.0001). In the HIT+ patients compared with the unconfirmed HIT patients, thrombocytopenia occurred 7 (range, 6-9) days after surgery versus 3 (range, 3-5) days (p < 0.0001), and kinetics of platelet count showed a biphasic pattern. Six HIT+ patients (25% [7.7-42.3]) presented with an arterial thromboembolic event. Diagnosis performances of HIT scoring systems were low. CONCLUSIONS: Confirmed HIT occurred predominantly in patients treated with IVUH. The timing of thrombocytopenia and the variation pattern of the postoperative platelet count are key factors in diagnosing HIT. The overall incidence of intracardiac thrombotic events was noted to be high.
Asunto(s)
Anticoagulantes/efectos adversos , Procedimientos Quirúrgicos Cardíacos/efectos adversos , Heparina/efectos adversos , Trombocitopenia/inducido químicamente , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Estudios ProspectivosRESUMEN
AIM: The assessment of diastolic function remains difficult in critical care patients because of unstable preload conditions. Described as fairly insensitive to preload changes, tissue Doppler velocity measurement at the lateral mitral annulus (e' (lat) ) may help evaluate diastolic function. Our aim was to prospectively evaluate e' (lat) changes in relation to fluid expansion in critically ill patients. METHODS: This prospective observational study was conducted in critically ill, mechanically ventilated, patients in sinus rhythm without previously known cardiac disease. Echocardiography was performed before and 1 hour after a fluid challenge (infusion of Gelofusine 500 ml in 30 minutes). Conventional pulsed wave Doppler indices of left ventricular diastolic function and tissue Doppler velocity lateral (e' (lat) ) and septal (e' (sept) ) mitral annulus velocity were measured, whereas hemodynamic data were simultaneously collected. RESULTS: Twenty patients (age, 55 ± 15 years; Simplified Acute Physiology Score II, 45 ± 10) were enrolled. Systolic function was preserved in all patients. Cardiac index increased (p < 0.05), as did early diastolic mitral velocity (E wave) (p = 0.001), and e' (lat) and e' (sept) (p = 0.02) after fluid challenge. CONCLUSIONS: This study confirms the preload dependence and limited clinical usefulness of most Doppler variables, such as e' (lat) , to evaluate diastolic function in intensive care unit patients. Indices, such as E/e', may be of interest in these cases.
Asunto(s)
Enfermedad Crítica , Ecocardiografía Doppler , Ecocardiografía Transesofágica , Válvula Mitral/diagnóstico por imagen , Disfunción Ventricular Izquierda/diagnóstico por imagen , Adulto , Anciano , Hemodinámica , Humanos , Persona de Mediana Edad , Válvula Mitral/fisiopatología , Estudios Prospectivos , Respiración ArtificialRESUMEN
OBJECTIVE: Fibrocytes are mesenchymal progenitors involved in normal and pathologic repair. The aims of this study were: 1) to quantify fibrocytes in bronchoalveolar lavage fluid from patients with or without acute lung injury and acute respiratory distress syndrome; and 2) to evaluate the prognostic value of bronchoalveolar lavage fibrocyte percentage in patients with acute lung injury and acute respiratory distress syndrome. DESIGN: Prospective cohort study. SETTING: Three intensive care units of a large tertiary referral center. PATIENTS: One hundred twenty-two ventilated patients requiring bronchoalveolar lavage were enrolled (62 acute respiratory distress syndrome, 30 acute lung injury, 30-ventilated patients without acute lung injury and acute respiratory distress syndrome). INTERVENTIONS: After bronchoalveolar lavage collection during standard care, the patients were followed up for 28 days and clinical outcome was recorded. Fibrocytes (CD45+/collagen 1+) were quantified in bronchoalveolar lavage by flow cytometry. Comparison of bronchoalveolar lavage fibrocyte percentage from patients with or without acute lung injury and acute respiratory distress syndrome was performed using a Wilcoxon test. A multivariate analysis using a Cox model was performed to study the independent predictors of survival. MEASUREMENTS AND MAIN RESULTS: Fibrocytes were detected in 90 of 92 (98%) bronchoalveolar lavages from patients with acute lung injury and acute respiratory distress syndrome. The median percentage of bronchoalveolar lavage fibrocytes was significantly higher in patients with acute lung injury and acute respiratory distress syndrome (5.0%) in comparison with ventilated control subjects (0.9%, p < .0001). After adjustment for age, comorbidity of malignancy, and severity of illness, a bronchoalveolar lavage fibrocyte percentage >6% was independently associated with a higher 28-day mortality in patients with acute lung injury and acute respiratory distress syndrome (hazard ratio [95% confidence interval] 6.15 [2.78-13.64], p ≤ .0001). Addition of bronchoalveolar lavage fibrocyte percentage in a clinical model predicting mortality in patients with acute lung injury and acute respiratory distress syndrome improved global fit and discriminatory capacity (c-statistic, 0.78-0.85; p = .007). CONCLUSIONS: Fibrocytes are detectable in bronchoalveolar lavage during acute lung injury and acute respiratory distress syndrome. A bronchoalveolar lavage fibrocyte percentage >6% provides an additive prognostic value to clinical predictors and may be useful to identify patients with acute lung injury and acute respiratory distress syndrome at highest risk of an adverse outcome.
Asunto(s)
Lesión Pulmonar Aguda/diagnóstico , Alveolos Pulmonares/citología , Lesión Pulmonar Aguda/patología , Factores de Edad , Anciano , Líquido del Lavado Bronquioalveolar/citología , Femenino , Citometría de Flujo , Humanos , Masculino , Persona de Mediana Edad , Pronóstico , Estudios Prospectivos , Alveolos Pulmonares/patología , Respiración Artificial , Síndrome de Dificultad Respiratoria/diagnóstico , Síndrome de Dificultad Respiratoria/patología , Resultado del TratamientoRESUMEN
BACKGROUND: Iron deficiency is the commonest cause of anaemia. It is apparent preoperatively in cardiac surgery patients and may influence transfusion requirements. In addition, iron deficiency per se is associated with fatigue. OBJECTIVE: To determine the prevalence of preoperative iron deficiency and its association with perioperative anaemia, blood transfusions and fatigue in cardiac surgery patients. SETTING: Academic hospital in Paris, France. PATIENTS: One hundred consecutive patients without known iron disorder and scheduled for cardiac surgery were prospectively included in this observational study. INTERVENTION: No intervention was performed. MEASUREMENTS: A biological iron profile (transferrin saturation, ferritin, soluble transferrin receptor and C-reactive protein) was assessed on the day of surgery. Diagnosis of iron deficiency was defined using a previously published algorithm. Patient fatigue was assessed before surgery and 1 week afterwards (day 7) using the Multidimensional Fatigue Inventory (MFI-20) score that quotes five distinctive dimensions of fatigue. RESULTS: Thirty-seven out of 100 patients were diagnosed with iron deficiency. These patients were younger [median (first-third quartile) 63 (43-70) vs. 70 (59-77) years (Pâ=â0.004)], and more often female (51 vs. 21%, Pâ=â0.003), than no iron deficiency patients. Preoperative iron deficiency was associated with lower preoperative haemoglobin levels (Pâ=â0.006) and higher perioperative transfusion rates during the first week (62 vs. 35%, Pâ=â0.019). Patients with iron deficiency but without anaemia (nâ=â25) received more packed red blood cells units than those without iron deficiency or anaemia (nâ=â50) [2 (0-2) vs. 0 (0-0) units, Pâ<â0.05). Preoperative iron deficiency was associated with higher score of physical fatigue on day 7 (Pâ=â0.01). CONCLUSION: Preoperative iron deficiency is frequent among cardiac surgery patients and is associated with anaemia, higher transfusion requirements and postoperative fatigue.
Asunto(s)
Anemia Ferropénica/complicaciones , Transfusión Sanguínea , Procedimientos Quirúrgicos Cardíacos/efectos adversos , Fatiga/etiología , Cardiopatías/cirugía , Deficiencias de Hierro , Adulto , Anciano , Anemia Ferropénica/sangre , Anemia Ferropénica/diagnóstico , Anemia Ferropénica/mortalidad , Biomarcadores/sangre , Proteína C-Reactiva/análisis , Procedimientos Quirúrgicos Cardíacos/mortalidad , Distribución de Chi-Cuadrado , Fatiga/diagnóstico , Fatiga/mortalidad , Femenino , Ferritinas/sangre , Cardiopatías/sangre , Cardiopatías/complicaciones , Hemoglobinas/análisis , Humanos , Masculino , Persona de Mediana Edad , Paris , Proyectos Piloto , Prevalencia , Estudios Prospectivos , Receptores de Transferrina/sangre , Medición de Riesgo , Factores de Riesgo , Factores de Tiempo , Transferrina/análisis , Resultado del TratamientoRESUMEN
OBJECTIVE: The aim of the present study was to assess the influence of preoperative statin therapy on postoperative mortality in high-risk patients after isolated valve surgery. DESIGN: An observational cohort study. SETTING: A 1,200-bed university hospital. PARTICIPANTS: All consecutive patients undergoing isolated nonemergent valve surgery with cardiopulmonary bypass between November 2005 and December 2007 were included. INTERVENTION: None. MEASUREMENTS AND MAIN RESULTS: During the period, 772 consecutive patients underwent nonemergent isolated valve surgery. Among them, 430 were high cardiovascular risk (defined by patients with 2 or more cardiovascular risk factors). In the high-risk cardiovascular patients, statin pretreatment was administered in 222 patients (52%). In multivariate analysis, after adjustment with a propensity score analysis, preoperative statin therapy was associated with a significant reduction of postoperative mortality in patients with high risk (odds ratio = 0.41; 95% confidence interval, 0.17-0.97; p = 0.04). Low left ventricular ejection fraction and elevated pulmonary artery pressure also were independently associated with increased postoperative mortality. By contrast, in the low-risk patient group, few patients received preoperative statin therapy (7%). CONCLUSIONS: This study suggests that preoperative statin therapy may have a potential beneficial effect on postoperative mortality after isolated cardiac valve surgery in high-risk cardiovascular patients.